En­tos lures for­mer Plexxikon CEO to guide push to­ward the clin­ic; Ex-Bris­tol My­ers im­munol­o­gy chief finds new home

Around the same time that En­tos CEO Tom Miller re­al­ized it was time to bring on a CSO to guide the com­pa­ny’s can­cer drugs in­to the clin­ic, Dai­ichi Sankyo was wind­ing down op­er­a­tions at its long­time sub­sidiary Plexxikon.

That led Miller to find Chao Zhang — Plexxikon’s for­mer CEO who “couldn’t have been more tai­lor-made for dri­ving our drug de­vel­op­ment pro­gram,” Miller said.

Zhang start­ed at En­tos ear­li­er this week, af­ter wrap­ping up a near­ly 21-year ca­reer at Plexxikon.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.